Company intelligence / Profile preview

Happitech

Amsterdam, North Holland, Netherlandshappitech.com ↗

Ownership: Private
Development stage: Commercial

Overview

Happitech has developed a CE-marked software solution that uses smartphone cameras to detect atrial fibrillation via PPG technology. The solution has been validated in over 13 clinical studies and monitors over 30,000 Afib patients monthly. It has served more than 500,000 unique users through hospital and platform partnerships. The company claims more than 30% market share for Afib monitoring solutions in the Netherlands

Therapeutic areas: Cardiovascular
Modalities: DeviceSoftware as a Medical Device (SaMD)
Industry: Physiological Monitoring

Partnerships

Numerous hospitals in the Netherlands; unspecified platform providers with whom they have integrated their SDK serving >500k users

Beyond the preview

Go deeper on Happitech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Happitech.

Explore the full profile